Ledger.Open graph →
SEC Form D · Amendment · filed July 20, 2018

PLIANT THERAPEUTICS, INC

Offering
$62.1M
Sold
$62.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Stefan Axell · Toronto, Ontario, CanadaDirectorManuel R. Rivera · Toronto, Ontario, CanadaExecDarren Dell · Toronto, Ontario, CanadaExecMichael Galgon · Kirkland, WAExec · DirectorTrent Yang · Washington, Washington, D.C.DirectorIan Campbell · Camden, MEDirectorJennifer Von Bismarck · Washington, Washington, D.C.DirectorAnna Ford · Camden, MEDirectorMJG Associates, Inc · Greenwich, CTDirectorAlexis N. Fortune · Co. Dublin, IrelandExec · DirectorEric R. Edell · NEW YORK, NYDirectorAnuv Ratan · Corte Madera, CADirectorAmber Ramsey · Camana Bay, Grand Cayman, Cayman IslandsDirectorGraeme Winder · Colorado Springs, CODirectorHarley Blakeman · COLUMBUS, OHDirectorArtem Milinchuk · Lewes, DEExecTimothy J. Gill · San Pedro, CAExecAndrew V. Valer · Denver, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗